CLINICAL TRIALS PROFILE FOR NARATRIPTAN HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for Naratriptan Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00282165 ↗ | Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order | Terminated | FPC De Kijvelanden, Poortugaal | Phase 4 | 2006-11-01 | In a double blind randomized clinical trial with cross-over design, treatment using naratriptan will be compared to placebo within a group of 30 convicts with psychiatric disorders such as psychosis or psychopathy with repeated aggressive outbursts resistant to conventional psychopharmacologic and other psychotherapeutic treatment. Hypothesis is that addition of naratriptan to the individual treatment regime reduces aggression -and improves general outcome- as compared to addition of placebo and is well tolerated in this group and under these conditions. |
| NCT00282165 ↗ | Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order | Terminated | UMC Utrecht | Phase 4 | 2006-11-01 | In a double blind randomized clinical trial with cross-over design, treatment using naratriptan will be compared to placebo within a group of 30 convicts with psychiatric disorders such as psychosis or psychopathy with repeated aggressive outbursts resistant to conventional psychopharmacologic and other psychotherapeutic treatment. Hypothesis is that addition of naratriptan to the individual treatment regime reduces aggression -and improves general outcome- as compared to addition of placebo and is well tolerated in this group and under these conditions. |
| NCT00487578 ↗ | Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction | Terminated | Clinvest | Phase 4 | 2006-10-01 | The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction. |
| NCT00487578 ↗ | Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction | Terminated | GlaxoSmithKline | Phase 4 | 2006-10-01 | The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction. |
| NCT00487578 ↗ | Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction | Terminated | Cady, Roger, M.D. | Phase 4 | 2006-10-01 | The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Naratriptan Hydrochloride
Condition Name
Clinical Trial Locations for Naratriptan Hydrochloride
Trials by Country
Clinical Trial Progress for Naratriptan Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Naratriptan Hydrochloride
Sponsor Name
